Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: a pilot study

Abstract

MSCs may have a delayed effect in reducing airway inflammation, airway hyper-responsiveness and remodeling in experimentally induced asthmatic cats. Results warrant additional investigation of MSC therapy for asthma in cats.